Infant Bacterial Therapeutics publishes Annual Report for 2021
March 31, 2022 02:00 ET
|
Infant Bacterial Therapeutics AB
Press release March 31, 2022 Infant Bacterial Therapeutics AB (publ) publishes today the Annual Report for 2021. The report is available on IBT’s website ibtherapeutics.com under the section...
FINANCIAL REPORT Q4 2021 - Jøtul AS
February 28, 2022 04:00 ET
|
Jøtul AS
The Jøtul Group (representing, as at 31 December 2021, Jøtul AS together with its subsidiaries) is one of the three largest suppliers of fireplaces in Europe and a significant player in North...
Infant Bacterial Therapeutics AB (publ), (IBT) bokslutskommuniké 1 januari – 31 december 2021
February 04, 2022 14:00 ET
|
Infant Bacterial Therapeutics AB
Pressmeddelande den 4 februari, 2022 VD kommenterar IBT:s pågående avgörande fas III-studie syftar till att ta fram data som förbättrar prematura spädbarns möjligheter att överleva. Det görs genom...
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – December 31, 2021
February 04, 2022 14:00 ET
|
Infant Bacterial Therapeutics AB
Press release February 4, 2022 Message from the CEO IBT’s ongoing pivotal phase lll clinical trial aims to generate data to improve survival possibilities of premature infants. This is...
FINANCIAL REPORT Q3 2021 - Jøtul AS
November 24, 2021 08:55 ET
|
Jøtul AS
The Jøtul Group (representing, as at 30 September 2021, Jotul Holdings SA together with its subsidiaries) is one of the three largest suppliers of fireplaces in Europe and a significant player in...
12 ReTech Corporation Released its Financial Report for the Quarter Ended September 30, 2021.
November 22, 2021 08:30 ET
|
12 Retech Corporation
Shows 180.3% Revenue Improvement Over Prior Comparable Period Results and Generates a GAAP Net Loss of $5.8 million. Las Vegas, NV, Nov. 22, 2021 (GLOBE NEWSWIRE) -- 12 ReTech...
Sprout AI Inc. Q3 Financial Report
November 01, 2021 08:30 ET
|
Sprout AI Inc.
VANCOUVER, Nov. 01, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Sprout AI Inc. (“Sprout AI” or the “Company”) (CSE: SPRT) has filed its unaudited interim Third Quarter (Q3) Financial Statement (FS)...
Infant Bacterial Therapeutics AB (publ), (IBT) Delårsrapport 1 januari – 30 september 2021
October 29, 2021 02:00 ET
|
Infant Bacterial Therapeutics AB
VD kommenterar Som bekant genomför IBT en stor fas III-studie (“The Connection Study”) vilket är den sista studien i vårt kliniska utvecklingsprogram med läkemedelskandidaten IBP-9414, som...
Infant Bacterial Therapeutics AB (publ), Interim report January 1-September 30, 2021
October 29, 2021 02:00 ET
|
Infant Bacterial Therapeutics AB
Infant Bacterial Therapeutics AB (publ), Interim report January 1-September 30, 2021 Message from the CEO As is well known, IBT is conducting a large phase III study ("The Connection Study"), the...
Jotul Holdings SA - Interim financial report for the half-year ended 30. June 2021
August 30, 2021 10:00 ET
|
Jøtul AS
In the first half of 2021, the Jotul Group reached a consolidated loss of MNOK 54.1 (H1 2020: loss of MNOK 68.5). The operating loss totaled MNOK 1.2 in H1 2021 (H1 2020: loss of MNOK 60.1). The 2021...